Scott Nelson Live

Finding Your Unfair Advantage Against Industry Goliaths: Interview with Happy Health CEO Dustin Freckleton

Proof Looks Different at Every Stage: Interview with Former SpectraWAVE CEO Eman Namati

Transitioning from a technical or academic background to a CEO role requires shifting focus from optimizing technology to managing commercial viability, team dynamics, and strategic trade-offs. Success in medical device startups hinges on balancing technical innovation with clinical workflow integration, often requirin...

Solving the 'What Next' Problem in Health Diagnostics: Interview with Vero Bioscience CEO Paul Coletta

Vero Bioscience’s "Vero Compass" platform bridges the gap between diagnostic health insights and actionable interventions by measuring the biological age of individual organs through a single blood draw. By analyzing protein signatures, the technology identifies organ-specific vulnerabilities, allowing for evidence-inf...

Building an Operating System for Faster Decisions: Interview with Cala Health CEO Deanna Harshbarger

Building a successful medtech startup requires a rigorous, data-driven approach to both product development and fundraising. Deanna Harshbarger, CEO of Cala Health, emphasizes that startups must balance immediate operational "sprints" with a long-term "marathon" vision, ensuring every decision is backed by solid financ...

Knowing When to Pivot Without Starting Over: Interview with ABK Biomedical CEO Michael Mangano

ABK Biomedical’s Eye90 radioembolization device represents a significant advancement in treating unresectable liver cancer by integrating radiopaque microspheres that allow for real-time, patient-specific dosing and immediate verification of treatment delivery. CEO Michael Mangano details the company’s strategic pivot ...

Building Commercial Conviction Before Launch: Interview with SetPoint Medical CEO Murthy Simhambhatla

Building and commercializing novel medical technology requires long-term strategic foresight, deep clinical conviction, and a clear health economic value proposition. Murthy Simhambhatla, CEO of SetPoint Medical, emphasizes that startups must visualize their commercial endgame years in advance to guide early-stage deve...

What Makes a Medtech Company Investable? Interview with Neuros Medical CEO David Veino

Neuros Medical’s Altius system addresses the significant unmet need of chronic post-amputation pain, a condition affecting 80% of the 2.5 million lower-limb amputees in the United States. By utilizing an on-demand, high-frequency nerve block, the device offers a non-opioid alternative for patients who have often failed...

Building Around Technology and Market Tailwinds: Interview with Adaptyx Biosciences CEO Vijit Sabnis

Changing Physician Workflows Requires More Than Clinical Evidence: Interview with Sonex Health CEO Bob Paulson

Designing for Access, Not Just Affordability: Interview with SS Innovations Founder Dr. Sudhir Srivastava

Three Hurdles to Medical Device Adoption: Interview with Esperto Medical CEO Aditya Rajagopal

Creating Consumer Demand for a New Category: Interview with Climatic CEO Eric Kau

Building Clinical Evidence Around Your Target Market: Interview with Teal Health CEO Kara Egan

Solving for Healthcare’s Broken Doorway: Interview with OnMed CEO Karthik Ganesh

Meeting Patients Where They Are: Interview with Clairity CEO Dr. Connie Lehman

Translating Academic IP into a Medtech Startup: Interview with Echopoint Medical CEO Antony Odell

Why Early Revenue is the Most Credible Proof in Medtech: Interview with restor3d CEO Kurt Jacobus

Finding the Clinical Need Hiding in Plain Sight: Interview with LightForce CEO Alfred Griffin

Regulatory Rigor as a Competitive Moat: Interview with Osteoboost CEO Laura Yecies

What It Takes to Win Physician Confidence: Interview with Secure Closure CEO Stephen Belcher